Filing Details
- Accession Number:
- 0001443984-23-000220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-07 13:35:24
- Reporting Period:
- 2023-08-04
- Accepted Time:
- 2023-08-07 13:35:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 825542 | Scotts Miracle-Gro Co | SMG | Agricultural Chemicals (2870) | 311414921 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1180171 | James Hagedorn | C/O The Scotts Miracle-Gro Company 14111 Scottslawn Road Marysville OH 43041 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-08-04 | 19,429 | $55.71 | 160,636 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2023-08-04 | 29,120 | $56.92 | 131,516 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2023-08-07 | 6,448 | $55.43 | 125,068 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2023-08-07 | 3 | $56.08 | 125,065 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 25,400 | Indirect | By 401(K) Plan |
| Common Shares | 1,475,074 | Indirect | HPLP |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.41 to $56.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.41 to $57.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.05 to $56.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- Pursuant to Exchange Act Rule 16a-1(a)(1), the reporting person may be deemed, solely for purposes of determining whether he is a beneficial owner of more than 10% of the common shares of the Issuer ("Common Shares"), to be the beneficial owner of the securities of the Issuer that are held by Hagedorn Partnership, L.P., a Delaware limited partnership in which the reporting person is a general partner (the "Partnership"). Represents the aggregate proportionate interest of the reporting person and those family members in whose holdings he may be deemed to have a pecuniary interest, in Common Shares held by the Partnership.
Billionaire Hedge Funds
